1 |
Show member pathways
|
13.1 |
TP53 MYC KRAS HRAS EGFR AKT1 |
2 |
Show member pathways
|
13.03 |
TP53 MYC KRAS HRAS EGFR AKT1 |
3 |
Show member pathways
|
12.98 |
TP53 MYC KRAS HRAS EGFR CDKN2A |
4 |
Show member pathways
Signal transduction PTEN pathway
23
|
12.88 |
TP53 MYC KRAS HRAS EGFR CDKN2A |
5 |
|
12.82 |
TP53 MYC KRAS HRAS EGFR CDKN2A |
6 |
|
12.8 |
TP53 MYC KRAS HRAS EGFR AKT1 |
7 |
Show member pathways
|
12.76 |
TP53 KRAS HRAS EGFR AKT1 |
8 |
Show member pathways
Apoptosis and survival Apoptotic TNF-family pathways
23
|
12.75 |
TP53 MYC KRAS HRAS CDKN2A AKT1 |
9 |
Show member pathways
|
12.72 |
TP53 KRAS HRAS EGFR CDKN2A AKT1 |
10 |
Show member pathways
CD27 Pathway
63
CD40 Signaling
63
CMV and MAPK Pathways
63
NF-KappaB Activation by EBV
63
NF-kappaB Activation by Viruses
63
PKR Pathway
63
SUMO Pathway
63
TNFR2 Pathway
63
|
12.71 |
TP53 KRAS HRAS EGFR AKT1 |
11 |
Show member pathways
|
12.71 |
TP53 MYC KRAS HRAS EGFR CDKN2A |
12 |
Show member pathways
|
12.67 |
TP53 MYC KRAS HRAS EGFR AKT1 |
13 |
Show member pathways
Angiopoietin-TIE2 Signaling
63
Development Angiopoietin - Tie2 signaling
23
Development PDGF signaling via STATs and NF-kB
23
Immune response IL-10 signaling pathway
23
|
12.63 |
TP53 MYC KRAS HRAS EGFR AKT1 |
14 |
Show member pathways
|
12.55 |
TP53 KRAS HRAS EGFR AKT1 |
15 |
Show member pathways
|
12.49 |
TP53 KRAS HRAS EGFR AKT1 |
16 |
Show member pathways
|
12.48 |
TP53 MYC KRAS HRAS EGFR AKT1 |
17 |
Show member pathways
|
12.45 |
MYC HRAS EGFR AKT1 |
18 |
Show member pathways
|
12.44 |
MYC KRAS HRAS AKT1 |
19 |
Show member pathways
|
12.44 |
KRAS HRAS EGFR AKT1 |
20 |
Show member pathways
Immune response IL-4 signaling pathway
23
Signal transduction AKT signaling
23
|
12.43 |
TP53 MYC HRAS AKT1 |
21 |
|
12.4 |
TP53 MYC MIR30C1 KRAS HRAS EGFR |
22 |
Show member pathways
Development EGFR signaling pathway
23
EGF Pathway
63
|
12.37 |
MYC KRAS HRAS EGFR AKT1 |
23 |
Show member pathways
Transcription Androgen Receptor nuclear signaling
23
|
12.36 |
TP53 HRAS EGFR AKT1 |
24 |
Show member pathways
Immune response Oncostatin M signaling via MAPK in human cells
23
|
12.35 |
TP53 KRAS HRAS EGFR AKT1 |
25 |
|
12.34 |
TP53 KRAS HRAS CDKN2A |
26 |
Show member pathways
|
12.33 |
KRAS HRAS EGFR AKT1 |
27 |
Show member pathways
|
12.31 |
TP53 MYC KRAS EGFR AKT1 |
28 |
|
12.27 |
TP53 MYC KRAS HRAS CDKN2A AKT1 |
29 |
Show member pathways
|
12.26 |
TP53 MYC KRAS HRAS EGFR AKT1 |
30 |
|
12.23 |
KRAS HRAS EGFR AKT1 |
31 |
|
12.23 |
TP53 MYC KRAS EGFR AKT1 |
32 |
Show member pathways
|
12.22 |
TP53 KRAS HRAS AKT1 |
33 |
Show member pathways
|
12.19 |
TP53 KRAS HRAS AKT1 |
34 |
|
12.19 |
TP53 MYC KRAS HRAS EGFR AKT1 |
35 |
|
12.16 |
MYC KRAS HRAS AKT1 |
36 |
|
12.16 |
TP53 MYC KRAS EGFR AKT1 |
37 |
Show member pathways
|
12.15 |
TP53 MYC KRAS HRAS AKT1 |
38 |
Show member pathways
|
12.13 |
KRAS HRAS EGFR AKT1 |
39 |
Show member pathways
Development EGFR signaling via PIP3
23
Development PDGF signaling via MAPK cascades
23
|
12.13 |
MYC KRAS HRAS EGFR AKT1 |
40 |
Show member pathways
|
12.12 |
MYC KRAS HRAS AKT1 |
41 |
Show member pathways
|
12.11 |
KRAS HRAS EGFR AKT1 |
42 |
Show member pathways
UVB-Induced MAPK Signaling
63
|
12.09 |
TP53 KRAS HRAS EGFR AKT1 |
43 |
|
12.06 |
TP53 KRAS HRAS AKT1 |
44 |
|
11.99 |
TP53 MYC KRAS HRAS CDKN2A AKT1 |
45 |
|
11.96 |
TP53 MYC KRAS HRAS AKT1 |
46 |
Show member pathways
|
11.85 |
KRAS HRAS AKT1 |
47 |
Show member pathways
|
11.79 |
TP53 CDKN2A AKT1 |
48 |
|
11.79 |
TP53 MYC KRAS HRAS CDKN2A AKT1 |
49 |
|
11.78 |
TP53 CDKN2A AKT1 |
50 |
|
11.78 |
KRAS HRAS AKT1 |